Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 169

1.

Hepatitis C virus-induced changes in microRNA 107 (miRNA-107) and miRNA-449a modulate CCL2 by targeting the interleukin-6 receptor complex in hepatitis.

Sarma NJ, Tiriveedhi V, Crippin JS, Chapman WC, Mohanakumar T.

J Virol. 2014 Apr;88(7):3733-43. doi: 10.1128/JVI.03060-13. Epub 2014 Jan 15.

2.

Hepatitis C virus mediated changes in miRNA-449a modulates inflammatory biomarker YKL40 through components of the NOTCH signaling pathway.

Sarma NJ, Tiriveedhi V, Subramanian V, Shenoy S, Crippin JS, Chapman WC, Mohanakumar T.

PLoS One. 2012;7(11):e50826. doi: 10.1371/journal.pone.0050826. Epub 2012 Nov 30.

3.

Hepatitis C virus-mediated enhancement of microRNA miR-373 impairs the JAK/STAT signaling pathway.

Mukherjee A, Di Bisceglie AM, Ray RB.

J Virol. 2015 Mar;89(6):3356-65. doi: 10.1128/JVI.03085-14. Epub 2015 Jan 14.

4.

Hepatitis C Virus-Induced Upregulation of MicroRNA miR-146a-5p in Hepatocytes Promotes Viral Infection and Deregulates Metabolic Pathways Associated with Liver Disease Pathogenesis.

Bandiera S, Pernot S, El Saghire H, Durand SC, Thumann C, Crouchet E, Ye T, Fofana I, Oudot MA, Barths J, Schuster C, Pessaux P, Heim MH, Baumert TF, Zeisel MB.

J Virol. 2016 Jun 24;90(14):6387-6400. doi: 10.1128/JVI.00619-16. Print 2016 Jul 15.

5.

Targeting miRNAs to treat Hepatitis C Virus infections and liver pathology: Inhibiting the virus and altering the host.

Thibault PA, Wilson JA.

Pharmacol Res. 2013 Sep;75:48-59. doi: 10.1016/j.phrs.2013.03.004. Epub 2013 Mar 27. Review.

PMID:
23541631
6.

Computational identification of hepatitis C virus associated microRNA-mRNA regulatory modules in human livers.

Peng X, Li Y, Walters KA, Rosenzweig ER, Lederer SL, Aicher LD, Proll S, Katze MG.

BMC Genomics. 2009 Aug 11;10:373. doi: 10.1186/1471-2164-10-373.

7.

Transcriptional suppression of miR-181c by hepatitis C virus enhances homeobox A1 expression.

Mukherjee A, Shrivastava S, Bhanja Chowdhury J, Ray R, Ray RB.

J Virol. 2014 Jul;88(14):7929-40. doi: 10.1128/JVI.00787-14. Epub 2014 Apr 30.

8.

Hepatitis C virus induced miR200c down modulates FAP-1, a negative regulator of Src signaling and promotes hepatic fibrosis.

Ramachandran S, Ilias Basha H, Sarma NJ, Lin Y, Crippin JS, Chapman WC, Mohanakumar T.

PLoS One. 2013 Aug 12;8(8):e70744. doi: 10.1371/journal.pone.0070744. eCollection 2013.

9.

Regulation of the MIR155 host gene in physiological and pathological processes.

Elton TS, Selemon H, Elton SM, Parinandi NL.

Gene. 2013 Dec 10;532(1):1-12. doi: 10.1016/j.gene.2012.12.009. Epub 2012 Dec 14. Review.

PMID:
23246696
10.

MicroRNA-135a Modulates Hepatitis C Virus Genome Replication through Downregulation of Host Antiviral Factors.

Sodroski C, Lowey B, Hertz L, Jake Liang T, Li Q.

Virol Sin. 2019 Apr;34(2):197-210. doi: 10.1007/s12250-018-0055-9. Epub 2018 Nov 19.

11.

The Role of MicroRNA in Pathogenesis and as Markers of HCV Chronic Infection.

Lee CH, Kim JH, Lee SW.

Curr Drug Targets. 2017;18(7):756-765. doi: 10.2174/1389450117666160401125213. Review.

PMID:
27033188
12.

MicroRNA-155 controls Toll-like receptor 3- and hepatitis C virus-induced immune responses in the liver.

Jiang M, Broering R, Trippler M, Wu J, Zhang E, Zhang X, Gerken G, Lu M, Schlaak JF.

J Viral Hepat. 2014 Feb;21(2):99-110. doi: 10.1111/jvh.12126. Epub 2013 Sep 11.

PMID:
24383923
13.

Exosome-Mediated Intercellular Communication between Hepatitis C Virus-Infected Hepatocytes and Hepatic Stellate Cells.

Devhare PB, Sasaki R, Shrivastava S, Di Bisceglie AM, Ray R, Ray RB.

J Virol. 2017 Feb 28;91(6). pii: e02225-16. doi: 10.1128/JVI.02225-16. Print 2017 Mar 15. Erratum in: J Virol. 2017 Apr 28;91(10 ):.

14.

Lipopolysaccharide and Tumor Necrosis Factor Alpha Inhibit Interferon Signaling in Hepatocytes by Increasing Ubiquitin-Like Protease 18 (USP18) Expression.

MacParland SA, Ma XZ, Chen L, Khattar R, Cherepanov V, Selzner M, Feld JJ, Selzner N, McGilvray ID.

J Virol. 2016 May 27;90(12):5549-5560. doi: 10.1128/JVI.02557-15. Print 2016 Jun 15.

15.

MCPIP1 suppresses hepatitis C virus replication and negatively regulates virus-induced proinflammatory cytokine responses.

Lin RJ, Chu JS, Chien HL, Tseng CH, Ko PC, Mei YY, Tang WC, Kao YT, Cheng HY, Liang YC, Lin SY.

J Immunol. 2014 Oct 15;193(8):4159-68. doi: 10.4049/jimmunol.1400337. Epub 2014 Sep 15.

16.

Decline of miR-124 in myeloid cells promotes regulatory T-cell development in hepatitis C virus infection.

Ren JP, Wang L, Zhao J, Wang L, Ning SB, El Gazzar M, Moorman JP, Yao ZQ.

Immunology. 2017 Feb;150(2):213-220. doi: 10.1111/imm.12680. Epub 2016 Nov 11.

17.

Acute Hepatitis C Virus Infection Induces Consistent Changes in Circulating MicroRNAs That Are Associated with Nonlytic Hepatocyte Release.

El-Diwany R, Wasilewski LN, Witwer KW, Bailey JR, Page K, Ray SC, Cox AL, Thomas DL, Balagopal A.

J Virol. 2015 Sep;89(18):9454-64. doi: 10.1128/JVI.00955-15. Epub 2015 Jul 8.

18.

An immunosuppressive function of interleukin-35 in chronic hepatitis C virus infection.

Liu S, Zhang Q, Shao X, Wang W, Zhang C, Jin Z.

Int Immunopharmacol. 2017 Sep;50:87-94. doi: 10.1016/j.intimp.2017.06.015. Epub 2017 Jun 20.

PMID:
28644966
19.

MicroRNA-130a inhibits HCV replication by restoring the innate immune response.

Li S, Duan X, Li Y, Liu B, McGilvray I, Chen L.

J Viral Hepat. 2014 Feb;21(2):121-8. doi: 10.1111/jvh.12131. Epub 2013 Jul 30.

PMID:
24383925
20.

Hepatitis C virus NS3 protein modulates the biological behaviors of malignant hepatocytes by altering the expression of host cell microRNA.

Zhang J, Ishigaki Y, Takegami T.

Mol Med Rep. 2015 Oct;12(4):5109-15. doi: 10.3892/mmr.2015.4041. Epub 2015 Jul 3.

PMID:
26151503

Supplemental Content

Support Center